| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/13/2004 | US6762038 Mammalian somatic cells having a homozygous disruption in the gene which encodes the endonbonuclease rnase l and a homyzgous disruption in the gene which encodes the double-stranded rna dependent kinase pkr are provided |
| 07/13/2004 | US6762031 Viral expression library for use as tools in gene therapy |
| 07/13/2004 | US6762030 Complexing; immunoassay, immunotherapy |
| 07/13/2004 | US6762029 An isolated nucleic acid molecule that encodes the amino acid sequence, cell culturing, binding to antibody, non-human transgenic animal, antithrombotic drugs, treating cardiovascular diseases, genetic engineering |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6762020 Methods of diagnosing breast cancer |
| 07/13/2004 | US6761914 And an antigen that is preferably a recombinant fusion protein; from seeds from oilseed crops, such as soybean, rapeseed, sunflower and palm |
| 07/13/2004 | US6761894 Immune response against intracellular pathogens and in particular mycobacterium tuberculosis. |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761892 Heat shock protein-based vaccines and immunotherapies |
| 07/13/2004 | US6761891 Medicament for treating a manifested lyme disease |
| 07/13/2004 | US6761890 Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine |
| 07/13/2004 | US6761882 Helical cytokine zalpha33 |
| 07/13/2004 | CA2163212C Therapeutic compounds |
| 07/08/2004 | WO2004057333A1 Millisecond activation switch for seven-transmembrane proteins |
| 07/08/2004 | WO2004057021A2 Molecular methods and compositions for detecting and quantifying respiratory viruses |
| 07/08/2004 | WO2004057018A2 Pseudomonas aeruginosa and klebsiella virulence genes, proteins, and their use |
| 07/08/2004 | WO2004057007A1 Preparation of antifreeze protein |
| 07/08/2004 | WO2004057004A2 Plant genes and their use in controlling abcission in plants |
| 07/08/2004 | WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | WO2004056997A1 A human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it |
| 07/08/2004 | WO2004056996A2 The escherichia coli csrc gene and uses thereof for biofilm modulation |
| 07/08/2004 | WO2004056993A1 Plant with reduced protein content in seed, method of constructing the same and method of using the same |
| 07/08/2004 | WO2004056979A2 Recombinant virus production for the manufacturing of vaccines |
| 07/08/2004 | WO2004056976A2 Process for coating cell-culture support |
| 07/08/2004 | WO2004056974A2 Mutations affecting carotenoid production |
| 07/08/2004 | WO2004056970A2 Chemo-enzymatic process for proteome-wide mapping of post-translational modification |
| 07/08/2004 | WO2004056969A2 Generation of plants with altered oil content |
| 07/08/2004 | WO2004056965A2 Nucleic acids encoding antifungal drug targets and methods of use |
| 07/08/2004 | WO2004056961A2 Methods of identifying compounds that modulate protein activity |
| 07/08/2004 | WO2004056960A2 Gene-coding polynucleotides of the chromosome of the bacterium chromobacterium violaceum, expression and activity of these polynucleotides and their applications |
| 07/08/2004 | WO2004056876A1 Polypeptides with antiviral activity |
| 07/08/2004 | WO2004056871A2 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | WO2004056870A2 Method for separation of antithrombin |
| 07/08/2004 | WO2004056869A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | WO2004056868A2 Nf-hev compositions and methods of use |
| 07/08/2004 | WO2004056867A2 Ion channel for testing pharmacological active compounds |
| 07/08/2004 | WO2004056866A1 Asthma susceptibility locus |
| 07/08/2004 | WO2004056863A2 Splice variant of human placental growth hormone |
| 07/08/2004 | WO2004056862A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | WO2004056861A2 Glycoisoforms of adiponectin and uses thereof |
| 07/08/2004 | WO2004056860A2 Chorionic somatomammotropin hormone splice variants |
| 07/08/2004 | WO2004056859A1 Il-8-like proteins |
| 07/08/2004 | WO2004056858A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 07/08/2004 | WO2004056857A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 07/08/2004 | WO2004056856A1 Inactive transcription factor tif-ia and uses thereof |
| 07/08/2004 | WO2004056855A1 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
| 07/08/2004 | WO2004056854A1 Molecular transporters for intracellular delivery and their applications |
| 07/08/2004 | WO2004056853A2 An immunomodulatory protein derived from trypanosomes and uses thereof |
| 07/08/2004 | WO2004056852A2 Cyanovirin variant-polymer conjugates |
| 07/08/2004 | WO2004056851A1 Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response |
| 07/08/2004 | WO2004056850A2 Mutant proteins showing increased secretion |
| 07/08/2004 | WO2004056391A1 A method of immunisation and agents useful for same |
| 07/08/2004 | WO2004056389A1 Hpv-16 and -18 l1 vlp vaccine |
| 07/08/2004 | WO2004056386A2 Nucleic acids involved in blood-brain barrier control |
| 07/08/2004 | WO2004056385A2 Modulation of activity of neurotrophins |
| 07/08/2004 | WO2004056347A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| 07/08/2004 | WO2004056310A2 Methods of diagnosis and treatment of interstitial lung disease |
| 07/08/2004 | WO2004056176A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 07/08/2004 | WO2004056173A2 Generation of plants with altered oil content |
| 07/08/2004 | WO2004043997A3 Chimeric autoprocessing polypeptides and uses thereof |
| 07/08/2004 | WO2004042361A3 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 07/08/2004 | WO2004041997A9 Immunotherapy regimens in hiv-infected patients |
| 07/08/2004 | WO2004041179A3 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation |
| 07/08/2004 | WO2004039954A3 Type 2 diabetes mellitus genes |
| 07/08/2004 | WO2004039835A3 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone |
| 07/08/2004 | WO2004035622A3 Antagonists il-15 |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004034966A3 Substances for preventing and treating autoimmune diseases |
| 07/08/2004 | WO2004033490A3 Hcmv derived immunomodulatory polypeptide |
| 07/08/2004 | WO2004031414A3 Method for diagnosing prostate cancer |
| 07/08/2004 | WO2004031231A3 Genes and polypeptides relating to prostate cancers |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004018517A3 POLYPEPTIDE HAVING GnSAF ACTIVITY AND SYNTHETIC ANTIBODIES |
| 07/08/2004 | WO2004015081A3 Methods for treating circadian rhythm phase disturbances |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004005887A3 Methods and compositions for the detection of pregnancy in ruminants |
| 07/08/2004 | WO2004003170A3 Agents capable of inhibiting ras and uses thereof |
| 07/08/2004 | WO2004003143A3 Viruses and virus-like particles for multiple antigen and target display |
| 07/08/2004 | WO2004001418A3 Method for identifying and extracting endotoxin |
| 07/08/2004 | WO2004000236A3 Modified sodium iodide symporter proteins and genes for imaging and cancer therapy |
| 07/08/2004 | WO2004000221A3 Compositions and methods for modulating lymphocyte activity |
| 07/08/2004 | WO2003104277A3 Stat6 activation gene |
| 07/08/2004 | WO2003104259A3 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF |
| 07/08/2004 | WO2003097872A3 G - protein coupled receptor marker molecules associated with colorectal lesions |
| 07/08/2004 | WO2003097687A3 Neuroprotective polypeptides and methods of use |
| 07/08/2004 | WO2003096986A3 Compositions and methods for treatment of wounds |
| 07/08/2004 | WO2003087309A3 Bdnf polymorphisms and association with bipolar disorder |
| 07/08/2004 | WO2003083081A3 Lipid-associated molecules |
| 07/08/2004 | WO2003079746A3 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 07/08/2004 | WO2003074565A3 Peptides for use in antitumor immunotherapy |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003060145A3 Compositions and methods relating to pancreatic specific genes and proteins |
| 07/08/2004 | WO2003060086A3 Napi type iib polypeptides and methods for making and using same |
| 07/08/2004 | WO2003058021A3 Novel apoptosis-inducing dna sequences |
| 07/08/2004 | WO2003050268A3 Enhancement of the immune response using cd36-binding domain |
| 07/08/2004 | WO2003046125A3 Hin-2 nucleic acid molecules, proteins, antibodies, homologues, receptors, and uses thereof |
| 07/08/2004 | WO2003031642A9 lovE VARIANT REGULATOR MOLECULES |
| 07/08/2004 | WO2003031639A8 Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof |
| 07/08/2004 | WO2003024990A3 Variants of corticotropin releasing hormone receptor type 1 and uses thereof |